The application of exhaled breath gas and exhaled breath condensate analysis in the investigation of the lower respiratory tract in veterinary medicine: A review

Veterinary Journal

Volumn 191, Issue 3, 2012, Pages 282-291

  Cathcart, M P ^a   Love, S ^a   Hughes, K J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

CO; Ethane; Exhaled breath; Exhaled breath condensate; Hydrogen peroxide; Leukotriene B 4; NO; Pentane; PH

Indexed keywords

8 ISOPROSTANE; C REACTIVE PROTEIN; CARBON MONOXIDE; CYTOKINE; ETHANE; HYDROGEN PEROXIDE; INTERLEUKIN 6; LEUKOTRIENE B4; NITRATE; NITRIC OXIDE; NITRITE; PENTANE;

ABSORPTION SPECTROSCOPY; ACID BASE BALANCE; ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY OBSTRUCTION; ASTHMA; BACTERIAL PNEUMONIA; BIOSENSOR; BREATH ANALYSIS; BRONCHIECTASIS; CHEMOLUMINESCENCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXHALED BREATH CONDENSATE ANALYSIS; EXHALED BREATH GAS ANALYSIS; EXPIRATORY FLOW RATE; GAS CHROMATOGRAPHY; HORSE; HUMAN; INTERSTITIAL LUNG DISEASE; LASER ABSORPTION SPECTROSCOPY; LIPID PEROXIDATION; LOWER RESPIRATORY TRACT; LUNG SARCOIDOSIS; NON INVASIVE MEASUREMENT; NONHUMAN; OXIDATIVE STRESS; PH MEASUREMENT; PULMONARY HYPERTENSION; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; REVIEW; SLEEP APNEA SYNDROME; SPECTROPHOTOMETRY; VETERINARY MEDICINE; VIRUS PNEUMONIA;

ANIMALS; BIOLOGICAL MARKERS; BREATH TESTS; HORSE DISEASES; HORSES; RESPIRATORY TRACT DISEASES;

ANIMALIA; MAMMALIA;

EID: 84857232487     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2011.08.016     Document Type: Review

References (124)

1. Antczak A., Kurmanowska Z., Kasielski M., Nowak D. Inhaled glucocorticosteroids decrease hydrogen peroxide level in expired air condensate in asthmatic patients. Respiratory Medicine 2000, 94:416-421.
2. Antuni J.D., Ward S., Cramer D.S., Kharitonov S.A., Barnes P.J. Uptake and elimination of exhaled carbon monoxide in patients with interstitial lung disease is related to the degree of impairment of carbon monoxide diffusion capacity [Abstract]. American Journal of Respiratory and Critical Care Medicine 1999, 159:A86.
3. Antuni J.D., Kharitonov S.A., Hughes D., Hodson M.E., Barnes P.J. Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis. Thorax 2000, 55:138-142.
4. Antus B., Barta I., Kullmann T., Lazar Z., Valyon M., Horvath I., Csiszer E. Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: A longitudinal study. American Journal of Respiratory and Critical Care Medicine 2010, 182:1492-1497.
5. ATS/ERS Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. American Journal of Respiratory and Critical Care Medicine 2005, 171:912-930.
6. Babior B.M. Phagocytes and oxidative stress. American Journal of Medicine 2000, 109:33-44.
7. Baldwin S.R., Simon R.H., Grum C.M., Ketai L.H., Boxer L.A., Devall L.J. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1986, 4:11-14.
8. Bernareggi M., Rossoni G., Clini E., Pasini E., Bachetti T., Cremona G., Ambrosino N., Berti F. Detection of nitric oxide in exhaled air of different animal species using a clinical chemiluminescence analyser. Pharmacological Research 1999, 39:221-224.
9. Beurden W.J., Harff G.A., Dekhuijzen P.N., van den Bosch M.J., Creemers J.P., Smeenk F.W. An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate. Respiratory Medicine 2002, 96:197-203.
10. Biernacki W., Kharitonov S.A., Barnes P.J. Carbon monoxide in exhaled air in patients with lower respiratory tract infection. European Respiratory Journal 1998, 12:345S.
11. Bloemen K., Lissens G., Desager K., Schoeters G. Determinants of variability of protein content, volume and pH of exhaled breath condensate. Respiratory Medicine 2007, 101:1331-1337.
12. Borrill Z.L., Starkey C., Vestbo J., Singh D. Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. European Respiratory Journal 2005, 25:269-274.
13. Borrill Z.L., Smith J.A., Naylor J., Woodcock A.A., Singh D. The effect of gas standardisation on exhaled breath condensate pH. European Respiratory Journal 2006, 28:251-252.
14. Borrill Z.L., Roy K., Singh D. Exhaled breath condensate biomarkers in COPD. European Respiratory Journal 2008, 32:472-486.
15. Burciaga-Robles L.O., Holland B.P., Step D.L., Krehbiel C.R., McMillen G.L., Richards C.J., Sims L.E., Jeffers J.D., Namjou K., McCann P.J. Evaluation of breath biomarkers and serum haptoglobin concentration for diagnosis of bovine respiratory disease in heifers newly arrived at a feedlot. American Journal of Veterinary Research 2009, 70:1291-1298.
16. Burvall K., Palmberg L., Larsson K. Metabolic activation of A549 human airway epithelial cells by organic dust: A study based on microphysiometry. Life Sciences 2002, 71:299-309.
17. Carpagnano G.E., Kharitonov S.A., Foschino-Barbaro M.P., Resta O., Gramiccioni E., Barnes P.J. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. European Respiratory Journal 2003, 21:589-593.
18. Carraro S., Folesani G., Corradi M., Zanconato S., Gaston B., Baraldi E. Acid-base equilibrium in exhaled breath condensate of allergic asthmatic children. Allergy 2005, 60:476-481.
19. Choi A.M., Alam J. Heme oxygenase-1: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. American Journal of Respiratory Cell and Molecular Biology 1996, 15:9-19.
20. Corradi M., Montuschi P., Donnelly L.E., Pesci A., Kharitonov S.A., Barnes P.J. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. American Journal of Respiratory and Critical Care Medicine 2001, 163:854-858.
21. Couetil L.L., Hoffman A.M., Hodgson J., Buechner-Maxwell V., Viel L., Wood J.L., Lavoie J.P. Inflammatory airway disease of horses. Journal of Veterinary Internal Medicine 2007, 21:356-361.
22. 4. The International Journal of Biochemistry and Cell Biology 1998, 30:173-178.
23. Deaton C.M., Marlin D.J., Smith N.C., Smith K.C., Newton R.J., Gower S.M., Cade S.M., Roberts C.A., Harris P.A., Schroter R.C., Kelly F.J. Breath condensate hydrogen peroxide correlates with both airway cytology and epithelial lining fluid ascorbic acid concentration in the horse. Free Radical Research 2004, 38:201-208.
24. Deaton C.M., Marlin D.J., Smith N.C., Harris P.A., Dagleish M.P., Schroter R.C., Kelly F.J. Effect of acute airway inflammation on the pulmonary antioxidant status. Experimental Lung Research 2005, 31:653-670.
25. Derksen F.J. Oxidant injury and nitric oxide: A role in exercise-induced pulmonary haemorrhage?. Veterinary Journal 1997, 153:119-121.
26. Do R., Bartlett K.H., Chu W., Dimich-Ward H., Kennedy S.M. Within- and between-person variability of exhaled breath condensate pH and NH4+ in never and current smokers. Respiratory Medicine 2008, 102:457-463.
27. Downey D., Elborn J.S. Nitric oxide, iNOS, and inflammation in cystic fibrosis. Journal of Pathology 2000, 190:115-116.
28. Duz M., Whittaker A.G., Love S., Parkin T.D., Hughes K.J. Exhaled breath condensate hydrogen peroxide and pH for the assessment of lower airway inflammation in the horse. Research in Veterinary Science 2009, 87:307-312.
29. Duz, M., 2009. Assessment of a methodology for determination of H2O2 concentration and pH in exhaled breath condensate in horses with and without lower airway inflammation. Thesis, Masters of Veterinary Medicine, University of Glasgow.
30. Effros R.M., Hoagland K.W., Bosbous M., Castillo D., Foss B., Dunning M., Gare M., Lin W., Sun F. Dilution of respiratory solutes in exhaled condensates. American Journal of Respiratory and Critical Care Medicine 2002, 165:663-669.
31. Effros R.M., Biller J., Foss B., Hoagland K., Dunning M.B., Castillo D., Bosbous M., Sun F., Shaker R. A simple method for estimating respiratory solute dilution in exhaled breath condensates. American Journal of Respiratory and Critical Care Medicine 2003, 168:1500-1505.
32. Effros R.M., Casaburi R., Su J., Dunning M., Torday J., Biller J., Shaker R. The effects of volatile salivary acids and bases on exhaled breath condensate pH. American Journal of Respiratory and Critical Care Medicine 2006, 173:386-392.
33. Fey, K., Schack, S., Sasse, H.H.L., 2001. Leukotriene B4 and bradykinin in breath condensate in horses with recurrent airway obstruction. In: Proceedings of the World Equine Airways Symposium, Edinburgh, UK, p. 18.
34. Formanek W., Inci D., Lauener R.P., Wildhaber J.H., Frey U., Hall G.L. Elevated nitrite in breath condensates of children with respiratory disease. European Respiratory Journal 2002, 19:487-491.
35. Ganas K., Loukides S., Papatheodorou G., Panagou P., Kalogeropoulos N. Total nitrite/nitrate in expired breath condensate of patients with asthma. Respiratory Medicine 2001, 95:649-654.
36. Gessner C., Hammerschmidt S., Kuhn H., Seyfarth H.J., Sack U., Engelmann L., Schauer J., Wirtz H. Exhaled breath condensate acidification in acute lung injury. Respiratory Medicine 2003, 97:1188-1194.
37. Goldoni M., Caglieri A., Andreoli R., Poli D., Manini P., Vettori M.V., Corradi M., Mutti A. Influence of condensation temperature on selected exhaled breath parameters. BMC Pulmonary Medicine 2005, 5:10.
38. Gustafsson L.E., Leone A.M., Persson M.G., Wiklund N.P., Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochemical and Biophysical Research Communications 1991, 181:852-857.
39. Hanazawa T., Kharitonov S.A., Barnes P.J. Increased nitrotyrosine in exhaled breath condensate of patients with asthma. American Journal of Respiratory and Critical Care Medicine 2000, 162:1273-1276.
40. Hietanen E., Bartsch H., Bereziat J.C., Camus A.M., McClinton S., Eremin O., Davidson L., Boyle P. Diet and oxidative stress in breast, colon and prostate cancer patients: A case-control study. European Journal of Clinical Nutrition 1994, 48:575-586.
41. Ho L.P., Faccenda J., Innes J.A., Greening A.P. Expired hydrogen peroxide in breath condensate of cystic fibrosis patients. European Respiratory Journal 1999, 13:103-106.
42. Horvath I., Donnelly L.E., Kiss A., Kharitonov S.A., Lim S., Chung K.F., Barnes P.J. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. American Journal of Respiratory and Critical Care Medicine 1998, 158:1042-1046.
43. Horvath I., Donnelly L.E., Kiss A., Paredi P., Kharitonov S.A., Barnes P.J. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: A new marker of oxidative stress. Thorax 1998, 53:668-672.
44. Horvath I., Hunt J., Barnes P.J. Exhaled breath condensate: Methodological recommendations and unresolved questions. European Respiratory Journal 2005, 26:523-548.
45. Hunt J.F., Fang K., Malik R., Snyder A., Malhotra N., Platts-Mills T.A., Gaston B. Endogenous airway acidification. Implications for asthma pathophysiology. American Journal of Respiratory and Critical Care Medicine 2000, 161:694-699.
46. Hunt J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. Journal of Allergy and Clinical Immunology 2002, 110:28-34.
47. Hunt J.F., Erwin E., Palmer L., Vaughan J., Malhotra N., Platts-Mills T.A., Gaston B. Expression and activity of pH-regulatory glutaminase in the human airway epithelium. American Journal of Respiratory and Critical Care Medicine 2002, 165:101-107.
48. Inglis S.K., Wilson S.M., Olver R.E. Secretion of acid and base equivalents by intact distal airways. American Journal of Physiology 2003, 284:855-862.
49. Jack C.I., Walshaw M.J., Tran J., Hind C.R., Evans C.C. Twenty-four-hour tracheal pH monitoring - A simple and non-hazardous investigation. Respiratory Medicine 1994, 88:441-444.
50. Jöbsis R.Q., Schellekens S.L., Fakkel-Kroesbergen A., Raatgeep R.H., de Jongste J.C. Hydrogen peroxide in breath condensate during a common cold. Mediators of Inflammation 2001, 10:351-354.
51. Kharitonov S.A., Yates D., Robbins R.A., Logan-Sinclair R., Shinebourne E.A., Barnes P.J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994, 343:133-135.
52. Kharitonov S.A., Robbins R.A., Yates D., Keatings V., Barnes P.J. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. American Journal of Respiratory and Critical Care Medicine 1995, 152:609-612.
53. Kharitonov S.A., Wells A.U., O'Connor B.J., Cole P.J., Hansell D.M., Logan-Sinclair R.B., Barnes P.J. Elevated levels of exhaled nitric oxide in bronchiectasis. American Journal of Respiratory and Critical Care Medicine 1995, 151:1889-1893.
54. Kharitonov S.A., Barnes P.J. Clinical aspects of exhaled nitric oxide. European Respiratory Journal 2000, 16:781-792.
55. Kharitonov S.A., Barnes P.J. Exhaled markers of pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2001, 163:1693-1722.
56. Kirschvink N., Marlin D., Delvaux F., Leemans J., Clercx C., Sparkes A., Gustin P. Collection of exhaled breath condensate and analysis of hydrogen peroxide as a potential marker of lower airway inflammation in cats. Veterinary Journal 2005, 169:385-396.
57. 2 and pH in exhaled breath condensate samples: Methodical and physiological aspects. Biomarkers 2008, 13:319-341.
58. Koczulla A.R., Noeske S., Herr C., Dette F., Pinkenburg O., Schmid S., Jörres R.A., Vogelmeier C., Bals R. Ambient temperature impacts on pH of exhaled breath condensate. Respirology 2011, 15:155-159.
59. Kostikas K., Papatheodorou G., Ganas K., Psathakis K., Panagou P., Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. American Journal of Respiratory and Critical Care Medicine 2002, 165:1364-1370.
60. Kostikas K., Papatheodorou G., Psathakis K., Panagou P., Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 2003, 124:1373-1380.
61. 4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005, 127:1553-1559.
62. 2 partial pressure. European Respiratory Journal 2007, 29:496-501.
63. Kullmann T., Barta I., Antus B., Valyon M., Horvath I. Environmental temperature and relative humidity influence exhaled breath condensate pH. European Respiratory Journal 2008, 31:474-475.
64. Leung T.F., Li C.Y., Yung E., Liu E.K.H., Lam C.W.K., Wong G.W.K. Clinical and technical factors affecting pH and other biomarkers in exhaled breath condensate. Pediatric Pulmonology 2006, 41:87-94.
65. Lewandowski K., Busch T., Lewandowski M., Keske U., Gerlach H., Falke K.J. Evidence of nitric oxide in the exhaled gas of Asian elephants (Elephas maximus). Respiratory Physiology 1996, 106:91-98.
66. Lewandowski K., Busch T., Lohbrunner H., Rensing S., Keske U., Gerlach H., Falke K.J. Low nitric oxide concentrations in exhaled gas and nasal airways of mammals without paranasal sinuses. Journal of Applied Physiology 1998, 85:405-410.
67. 2 concentrations. Journal of Breath Research 2011, 10.1088/1752-7155/5/1/011001.
68. Liu L., Urban P., Hunt J.F., Wilkinson P., Laning K., Gaston B. Changes in exhaled nitric oxide and breath pH during fluticasone wean in asthma. Respiration 2010, 79:193-199.
69. Loukides S., Horvath I., Wodehouse T., Cole P.J., Barnes P.J. Elevated levels of expired breath hydrogen peroxide in bronchiectasis. American Journal of Respiratory and Critical Care Medicine 1998, 158:991-994.
70. Loukides S., Bouros D., Papatheodorou G., Panagou P., Siafakas N.M. The relationships among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest 2002, 121:338-346.
71. Lundberg J.O., Farkas-Szallasi T., Weitzberg E., Rinder J., Lidholm J., Anggaard A., Hokfelt T., Lundberg J.M., Alving K. High nitric oxide production in human paranasal sinuses. Nature Medicine 1995, 1:370-373.
72. Maziak W., Loukides S., Culpitt S., Sullivan P., Kharitonov S.A., Barnes P.J. Exhaled nitric oxide in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 1998, 157:998-1002.
73. McCafferty J.B., Bradshaw T.A., Tate S., Greening A.P., Innes J.A. Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentrations. Thorax 2004, 59:694-698.
74. Mendis S., Sobotka P.A., Leja F.L., Euler D.E. Breath pentane and plasma lipid peroxides in ischemic heart disease. Free Radical Biology and Medicine 1995, 19:679-684.
75. Mills P.C., Marlin D.J., Demoncheaux E., Scott C., Casas I., Smith N.C., Higenbottam T. Nitric oxide and exercise in the horse. Journal of Physiology 1996, 495:863-874.
76. Montuschi P., Ciabattoni G., Paredi P., Pantelidis P., du Bois R.M., Kharitonov S.A., Barnes P.J. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. American Journal of Respiratory and Critical Care Medicine 1998, 158:1524-1527.
77. Montuschi P., Corradi M., Ciabattoni G., Nightingale J., Kharitonov S.A., Barnes P.J. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. American Journal of Respiratory and Critical Care Medicine 1999, 160:216-220.
78. Montuschi P., Kharitonov S.A., Ciabattoni G., Corradi M., van Rensen L., Geddes D.M., Hodson M.E., Barnes P.J. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000, 55:205-209.
79. Muscatello G., Gilkerson J.R., Browning G.F. Detection of virulent Rhodococcus equi in exhaled air samples from naturally infected foals. Journal of Clinical Microbiology 2009, 47:734-737.
80. Mutlu G.M., Garey K.W., Robbins R.A., Danziger L.H., Rubinstein I. Collection and analysis of exhaled breath condensate in humans. American Journal of Respiratory and Critical Care Medicine 2001, 164:731-737.
81. Nickmilder M., de Burbure C., Carbonnelle S., Dumont X., Bernard A., Derouane A. Increase of exhaled nitric oxide in children exposed to low levels of ambient ozone. Journal of Toxicology and Environmental Health A 2007, 70:270-274.
82. Nowak D., Kasielski M., Antczak A., Pietras T., Bialasiewicz P. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respiratory Medicine 1999, 93:389-396.
83. 2 and thiobarbituric acidreactive substances (TBARS) by healthy subjects. Free Radical Biology and Medicine 2001, 30:178-186.
84. Ojoo J.C., Mulrennan S.A., Kastelik J.A., Morice A.H., Redington A.E. Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Thorax 2005, 60:22-26.
85. Olopade C.O., Christon J.A., Zakkar M., Hua C., Swedler W.I., Scheff P.A., Rubinstein I. Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 1997, 111:1500-1504.
86. Paget-Brown A.O., Ngamtrakulpanit L., Smith A., Bunyan D., Hom S., Nguyen A., Hunt J.F. Normative data for pH of exhaled breath condensate. Chest 2006, 129:426-430.
87. Paredi P., Kharitonov S.A., Barnes P. Elevation of exhaled ethane concentration in asthma. American Journal of Respiratory and Critical Care Medicine 2000, 162:1450-1454.
88. Paredi P., Kharitonov S.A., Leak D., Ward S., Cramer D., Barnes P.J. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2000, 162:369-373.
89. Paredi P., Kharitonov S.A., Leak D., Shah P.L., Cramer D., Hodson M.E., Barnes P.J. Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction. American Journal of Respiratory and Critical Care Medicine 2000, 161:1247-1251.
90. 4 in the canine exhaled breath: Standardization of a technique of sample collection. Veterinary Research Communications 2003, 27:425-428.
91. Pirie R.S., Collie D.D., Dixon P.M., McGorum B.C. Evaluation of nebulised hay dust suspensions (HDS) for the diagnosis and investigation of heaves. 2: Effects of inhaled HDS on control and heaves horses. Equine Veterinary Journal 2002, 34:337-342.
92. Phillips M., Herrera J., Krishnan S., Zain M., Greenberg J., Cataneo R.N. Variation in volatile organic compounds in the breath of normal humans. Journal of Chromatography B: Biomedical Sciences and Applications 1999, 729:75-88.
93. Prieto L., Orosa B., Barato D., Marin J. The effect of different periods of argon deaeration on exhaled breath condensate pH. Journal of Asthma 2011, 48:319-323.
94. 4 concentrations in exhaled condensate as a noninvasive method for assessing mediators of inflammation in the lungs of calves. American Journal of Veterinary Research 2000, 61:742-749.
95. Reinhold P., Kirschvink N., Theegarten D., Berndt A. An experimentally induced Chlamydia suis infection in pigs results in severe lung function disorders and pulmonary inflammation. Veterinary Research 2008, 39:35.
96. Ricciardolo F.L., Gaston B., Hunt J. Acid stress in the pathology of asthma. Journal of Allergy and Clinical Immunology 2004, 113:610-619.
97. Riely C.A., Cohen G., Lieberman M. Ethane evolution: A new index of lipid peroxidation. Science 1974, 183:208-210.
98. Robroeks C.M., Rijkers G.T., Jöbsis Q., Hendriks H.J., Damoiseaux J.G., Zimmermann L.J., van Schayck O.P., Dompeling E. Increased cytokines, chemokines and soluble adhesion molecules in exhaled breath condensate of asthmatic children. Clinical and Experimental Allergy 2010, 40:77-84.
99. Roller C.B., Holland B.P., McMillen G., Step D.L., Krehbiel C.R., Namjou K., McCann P.J. Measurement of exhaled nitric oxide in beef cattle using tunable diode laser absorption spectroscopy. Applied Optics 2007, 46:1333-1342.
100. Samitas K., Chorianopoulus D., Vittorakis S., Zervas E., Economidou E., Papatheodorou G., Loukides S., Gaga M. Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity. Journal of Respiratory Medicine 2009, 103:750-756.
101. Scheideler L., Manke H.G., Schwulera U., Inacker O., Hammerle H. Detection of nonvolatile macromolecules in breath. A possible diagnostic tool?. American Review of Respiratory Disease 1993, 148:778-784.
102. Schleiss M.B., Holz O., Behnke M., Richter K., Magnussen H., Jorres R.A. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. European Respiratory Journal 2000, 16:1115-1118.
103. Sparkes A.H., Mardell E.J., Deaton C., Kirschvink N., Marlin D. Exhaled breath condensate (EBC) collection in cats - Description of a non-invasive technique to investigate airway disease. Journal of Feline Medicine and Surgery 2004, 6:335-338.
104. Stanek A.H., Roberts J.D., Zapol W.M., Falke K.J., Liggins G.C., Liggins J. Thoracic circumference and nitric oxide activity in the free diving Weddell seal. Antarctic Journal of the United States 1995, 29:172-174.
105. Sumino H., Nakamura T., Kanda T., Sato K., Sakamaki T., Takahashi T., Saito Y., Hoshino J., Kurashina T., Nagai R. Effect of enalapril on exhaled nitric oxide in normotensive and hypertensive subjects. Hypertension 2000, 36:934-940.
106. Sutton D.G., Bahr A., Preston T., Christley R.M., Love S., Roussel A.J. Validation of the 13C-octanoic acid breath test for measurement of equine gastric emptying rate of solids using radioscintigraphy. Equine Veterinary Journal 2003, 35:27-33.
107. Sweeney C.R., Rossier Y., Ziemer E.L., Lindborg S.R. Effect of prior lavage on bronchoalveolar lavage fluid cell population of lavaged and unlavaged lung segments in horses. American Journal of Veterinary Research 1994, 55:1501-1504.
108. Tate S., MacGregor G., Davis M., Innes J.A., Greening A.P. Airways in cystic fibrosis are acidified: Detection by exhaled breath condensate. Thorax 2002, 57:926-929.
109. Teng Y., Sun P., Zhang J., Yu R., Bai J., Huang M., Adcock I.M., Barnes P.J. Hydrogen peroxide in exhaled breath condensate in asthma: A promising biomarker?. Chest 2011, 10.1378/chest.10-2816.
110. Thomas S.R., Kharitonov S.A., Scott S.F., Hodson M.E., Barnes P.J. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. Chest 2000, 117:1085-1089.
111. van de Kant K.D., Klaassen E.M., Jöbsis Q., Koers K., Rijkers G.T., van der Grinten C.P., van Schayck O.C., Passos V.L., Dompeling E. Wheezing in preschool children is associated with increased levels of cytokines/chemokines in exhaled breath condensate. Journal of Allergy and Clinical Immunology 2010, 126:669-671.
112. Vaughan J., Ngamtrakulpanit L., Pajewski T.N., Turner R., Nguyen T.A., Smith A., Urban P., Hom S., Gaston B., Hunt J. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. European Respiratory Journal 2003, 22:889-894.
113. Wells K., Vaughan J., Pajewski T.N., Hom S., Ngamtrakulpanit L., Smith A., Nguyen A., Turner R., Hunt J. Exhaled breath condensate pH assays are not influenced by oral ammonia. Thorax 2005, 60:27-31.
114. Wendland B.E., Aghdassi E., Tam C., Carrrier J., Steinhart A.H., Wolman S.L., Baron D., Allard J.P. Lipid peroxidation and plasma antioxidant micronutrients in Crohn's disease. American Journal of Clinical Nutrition 2001, 74:259-264.
115. Whittaker A.G., Love S., Parkin T.D., Duz M., Hughes K.J. Stabling causes a significant increase in the pH of the equine airway. Equine Veterinary Journal 2009, 41:940-943.
116. Whittaker A.G., Love S., Parkin T.D., Duz M., Hughes K.J. Assessment of the impact of collection temperature and sampler design on the measurement of exhaled breath condensate pH in healthy horses. The Veterinary Journal. 2012, 191:208-212.
117. Wyse C.A., Preston T., Yam P.S., Sutton D.G., Christley R.M., Hotchkiss J.W., Mills C.A., Glidle A., Cumming D.R., Cooper J.M., Love S. Current and future uses of breath analysis as a diagnostic tool. Veterinary Record 2004, 154:353-360.
118. Wyse C.A., Love S., Christley R.M., Yam P.S., Cooper J.M., Cumming D.R., Preston T. Validation of a method for collection and assay of pentane in the exhaled breath of the horse. Research in Veterinary Science 2004, 76:109-112.
119. Wyse C.A., Hammond J., Arteaga A., Cumming D., Cooper J.M., McEwan J.D., Yam P.S. Collection and analysis of exhaled breath condensate hydrogen peroxide in conscious healthy dogs. Veterinary Record 2004, 155:744-746.
120. Wyse C., Cathcart A., Sutherland R., Ward S., McMillan L., Gibson G., Padgett M., Skeldon K. Effect of maximal dynamic exercise on exhaled ethane and carbon monoxide levels in human, equine, and canine athletes. Comparative Biochemistry and Physiology 2005, 141:239-246.
121. Wyse C.A., Skeldon K., Hotchkiss J.W., Gibson G., Yam P.S., Christley R.M., Preston T., Cumming D.R., Padgett M., Cooper J.C., Love S. Effects of changes to the stable environment on the exhalation of ethane, carbon monoxide and hydrogen peroxide by horses with respiratory inflammation. Veterinary Record 2005, 157:408-412.
122. Wyse C.A., Nixon C., McLaughlin M., Dowell F.J., Philbey A.W. Evidence for the expression and enzymatic activity of haem oxygenase-1 in the lungs of horses. Veterinary Record 2006, 158:795-797.
123. Zietkowski Z., Tomasiak-Lozowska M.M., Skiepko R., Mroczko B., Szmitkowski M., Bodzenta-Lukaszyk A. High-sensitivity C-reactive protein in the exhaled breath condensate and serum in stable and unstable asthma. Respiratory Medicine 2009, 103:379-385.
124. Zietkowski Z., Tomasiak-Lozowska M.M., Skiepko R., Zietkowska E., Bodzenta-Lukaszyk A. Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients. Respiratory Research 2010, 11:110.